Rutgers-RWJMS is a clinical research site located in New Brunswick, New Jersey, United States 08901.
Crixeo Health Trust Score: 73/100 (FAIR). This profile has not yet been claimed by the site owner.
Rutgers-RWJMS has participated in 9 clinical trials with 1 currently active.
Therapeutic areas: Degenerative Mitral Valve Disease, Mitral Regurgitation, Mitral Insufficiency.
Sponsors: Edwards Lifesciences, Rutgers, The State University of New Jersey, Progenity, Inc..
Trust Score: 73/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Rutgers-RWJMS has a Crixeo Trust Score of 73/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Rutgers-RWJMS has 9 clinical trials on record, with 1 currently active. Their work covers Degenerative Mitral Valve Disease, Mitral Regurgitation, Mitral Insufficiency.
Yes — Rutgers-RWJMS holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.